Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/the-participation-of-atfx-in-the-acbc-nsw-chinese-new-year-gala-2025-served-to-enhance-business-relationships-between-australia-and-china/